Tomasz Swierkosz, M.D., PHD
Cardiovascular Disease Physician in Lawton, Oklahoma.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 24,795 in Cardiovascular Disease Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Source: CMS Medicare Part D Prescriber Public Use File, 2023
What the federal data shows
Tomasz Swierkosz, M.D., PHD reported a CMS MIPS final score of 91.2/100 - above the 83.1 national average - and filed 1,105 Medicare Part D claims in 2023.
- 91.2/100
- MIPS score · +8 vs avg
- 1K
- Part D claims, 2023
- 88%
- generic prescribing
- Likely
- board-certified (heuristic)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
Tomasz Swierkosz, M.D., PHD's MIPS score vs every scored U.S. clinician
CMS Merit-based Incentive Payment System (MIPS) final score, 2023, the federal quality measure
91 Top 37% higher than 63% of 477,587 scored providers
Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source CMS Merit-based Incentive Payment System (MIPS) · 2023
Where Tomasz Swierkosz, M.D., PHD sits
This provider among cardiovascular disease physician peers
Across the 8,753 cardiovascular disease physician providers who report both Medicare Part D prescribing and a MIPS quality score, Tomasz Swierkosz, M.D., PHD writes more Part D claims than 24% of them and scores higher on MIPS quality than 65% - placing this provider in the lower-volume, high-quality quadrant. Volume reflects patient-panel size and specialty, not quality; the two axes are independent.
Part D claim volume vs MIPS quality, by specialty percentile
Each dot is one cardiovascular disease physician peer from a representative sample of 60; the gold marker is Tomasz Swierkosz, M.D., PHD. Source: CMS Medicare Part D Prescriber data and the CMS Merit-based Incentive Payment System, 2023.
Tomasz Swierkosz, M.D., PHD practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting + 2 hospital affiliations - signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about Tomasz Swierkosz, M.D., PHD?
High performer (top quartile)Primary specialty
Medicare Part D claims
MIPS final score
Specialty distribution in Oklahoma
How Cardiovascular Disease Physician compares to other specialties among Oklahoma providers
Cardiovascular Disease Physician ranks #55 among Oklahoma's specialties (0.2% of in-state providers)
Each bar is a specialty's share of the Oklahoma provider total, by primary NUCC taxonomy. The highlighted bar is Cardiovascular Disease Physician; the long tail of smaller specialties is omitted for legibility.
Medicare quality performance, MIPS
Tomasz Swierkosz, M.D., PHD's 2023 MIPS final score plotted against the Cardiovascular Disease Physician national average
- MIPS Final Score
- 91.2/100
- vs 83.1 national avg · 2023 performance year
MIPS final score (Cardiovascular Disease Physician) - 91.2/100 vs national avg 83.1
Quality benchmarks
- National MIPS avg 2023 reporting year
- Quality dim CMS Quality category
- Specialty volume Cardiovascular Disease Physician US NPIs
91.2/100 MIPS final score - 8.1 pts above the 83.1 national average
Quality, Cost, Promoting Interoperability, and Improvement Activities composite score for the 2023 performance year. Specialty: Cardiovascular Disease Physician. Quality dim: 79.3.
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Tomasz Swierkosz, M.D., PHD appears in the CMS NPPES registry as a Cardiovascular Disease Physician provider holding M.D., PHD credentials at 3106 NW ARLINGTON AVE, Lawton, OK, 73505, with a listed phone of (580) 250-4278. NPI 1386629111 was issued on 12/14/2005.
Medicare Part D records for calendar year 2023 show 1,105 prescription claims written by this provider, covering 211 Medicare beneficiaries and totaling roughly $105K in drug spend, split 12% brand-name and 88% generic by claim count. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 91.2/100 for the 2023 performance year (Quality 79.3), compared with the national average of 83.1.
Cardiovascular Disease Physician is a mid-sized specialty nationwide, with 24,795 enrolled providers across 54 states and an average of 3,033 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline.
Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist, always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.
Practice Address
Provider Details
| NPI | 1386629111 |
|---|---|
| Specialty | Cardiovascular Disease Physician |
| Credentials | M.D., PHD |
| Gender | Male |
| NPI Issued | 12/14/2005 |
Verify this provider's license
PlainDoctor pulls this profile from the CMS NPPES public registry. Confirm Tomasz Swierkosz, M.D., PHD's current license status, disciplinary history, and board certifications with the Oklahoma State Board of Medical Licensure in Oklahoma before relying on this page for a clinical or care decision.
How we sourced this profile
Profile fields combine the CMS NPPES monthly snapshot (provider directory, taxonomy, and address) with calendar-year 2023 Medicare Part D and MIPS public-use files when records are present. NPI 1386629111 is the unique 10-digit identifier CMS uses to link Swierkosz across every Medicare, Medicaid, and HIPAA-covered transaction. Read full methodology →
CMS Quality Score (MIPS)
Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.
Reporting: Alternative Payment Model
Hospital and facility affiliations
Facilities where Tomasz Swierkosz, M.D., PHD bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" - a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.
Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).
Industry payments received (2024) - CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for Tomasz Swierkosz, M.D., PHD. Source: openpaymentsdata.cms.gov.
Total received
$218
Largest payer
Boston Scientific Corporation
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias, they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
Brand vs generic prescribing mix · Typical
12% brand-name claims vs 88% generic, on 1,105 2023 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
Prescribing Breakdown
- 30-Day Fills
- 2,881
- Total Day Supply
- 85,657
- Brand vs Generic
- 12% brand / 88% generic
- Brand Drug Cost
- $86K
- Generic Drug Cost
- $19K
Patient Demographics
- Average Patient Age
- 72.9 years
- Avg HCC Risk Score
- 1.60
- Gender Split
- 56% female / 44% male
- Age Distribution
- <65: 33, 65-74: 88, 75-84: 63, 85+: 27
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
What Tomasz Swierkosz, M.D., PHD prescribes most
Top Medicare Part D drugs by claim count, 2023
- Lisinopril
Lisinopril
108 claims
- Atorvastatin Calcium
Atorvastatin Calcium
105 claims
- Losartan Potassium
Losartan Potassium
104 claims
- Metoprolol Tartrate
Metoprolol Tartrate
101 claims
- Clopidogrel
Clopidogrel
98 claims
- Metoprolol Succinate
Metoprolol Succinate
86 claims
- Eliquis
Eliquis
77 claims
- Nitroglycerin
Nitroglycerin
71 claims
| Drug | Claims |
|---|---|
| Lisinopril | 108 |
| Atorvastatin Calcium | 105 |
| Losartan Potassium | 104 |
| Metoprolol Tartrate | 101 |
| Clopidogrel Clopidogrel Bisulfate | 98 |
| Metoprolol Succinate | 86 |
| Eliquis Apixaban | 77 |
| Nitroglycerin | 71 |
| Amlodipine Besylate | 58 |
| Carvedilol | 54 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Cardiovascular Disease Physician Overview
How Tomasz Swierkosz, M.D., PHD fits within the Cardiovascular Disease Physician landscape nationally.
Tomasz Swierkosz, M.D., PHD's 1,105 claims are below the specialty average of 3,033.
Nearby Cardiovascular Disease Physician Providers in Oklahoma
Other clinicians with the same primary specialty enrolled in Oklahoma, drawn from the same CMS NPPES roster as Swierkosz.
Compare Cardiovascular Disease Physician nationally: see state-by-state distribution →
Before you book an appointment
Use this federal record as your verification checklist, not as a recommendation.
- Confirm the NPI record is current in the official CMS registry, providers update their own NPPES details, and moves can lag. Verify this NPI
- Check the active license and any disciplinary history with the Oklahoma medical board, federal registration is not a license check. Credential verification guide
- Weigh a second option: compare this provider with a nearby Cardiovascular Disease Physician peer on Medicare volume and prescribing patterns. Compare providers
Medicare Part D and MIPS figures describe practice patterns in federal programs only, they are not quality ratings, and PlainDoctor does not rate, rank, or recommend providers.
Healthcare Guides
Learn more about finding, verifying, and understanding healthcare providers.
Explore Oklahoma
Frequently Asked Questions
What is Tomasz Swierkosz, M.D., PHD's specialty? ▼
How much does Tomasz Swierkosz, M.D., PHD prescribe under Medicare Part D? ▼
What is Tomasz Swierkosz, M.D., PHD's Medicare quality score? ▼
Where is Tomasz Swierkosz, M.D., PHD located? ▼
What is Tomasz Swierkosz, M.D., PHD's NPI number? ▼
Does Tomasz Swierkosz, M.D., PHD prescribe more brand-name or generic drugs? ▼
How many Cardiovascular Disease Physician providers are there in the US? ▼
What drugs does Tomasz Swierkosz, M.D., PHD prescribe most often? ▼
Does Tomasz Swierkosz, M.D., PHD accept Medicare? ▼
How can I verify Tomasz Swierkosz, M.D., PHD's credentials? ▼
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Quality Performance
- CMS Merit-based Incentive Payment System (MIPS) - 2023 performance year.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology